Spots Global Cancer Trial Database for cytopenia
Every month we try and update this database with for cytopenia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy | NCT02143830 | Fanconi Anemia Severe Marrow F... Myelodysplastic... Acute Myelogeno... | Busulfan Cyclophosphamid... Fludarabine rabbit ATG G-CSF Peripheral bloo... | 3 Months - | Children's Hospital Medical Center, Cincinnati | |
| Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study | NCT03733249 | Acute Lymphobla... Leukemia, Acute... Lymphoma, Non-H... Myelodysplastic... Primary Immunod... Anemia, Aplasti... Hemoglobinopath... Cytopenia Fanconi Anemia Diamond Blackfa... Thalassemia Anemia, Sickle ... | Rimiducid rivogenlecleuce... | 1 Month - 18 Years | Bellicum Pharmaceuticals | |
| Pre-myeloid Cancer and Bone Marrow Failure Clinic Study | NCT02958462 | Myeloid Maligna... Inherited Bone ... Clonal Expansio... Cytopenia Bone Marrow Fai... Clonal Cytopeni... Clonal Hematopo... Hematologic Neo... Hematopoietic a... Hereditary Neop... Idiopathic Cyto... Idiopathic Dysp... Low Risk Myelod... | Biospecimen Col... Bone Marrow Bio... Punch Biopsy Buccal Swab Clinical Evalua... Genetic Counsel... Quality-of-Life... Electronic Heal... | 18 Years - | Mayo Clinic | |
| The Efficacy of Coenzyme Q10 And Curcumin in Patients With Myelodysplastic Syndromes | NCT00247026 | Myelodysplastic... | curcumin; coenz... | 16 Years - | Hadassah Medical Organization | |
| Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant | NCT02065869 | Acute Lymphobla... Leukemia, Acute... Lymphoma, Non-H... Myelodysplastic... Primary Immunod... Anemia, Aplasti... Osteopetrosis Hemoglobinopath... Cytopenia Fanconi Anemia Diamond Blackfa... Thalassemia Anemia, Sickle ... | BPX-501 T cells Rimiducid | 1 Month - 18 Years | Bellicum Pharmaceuticals | |
| Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant | NCT02065869 | Acute Lymphobla... Leukemia, Acute... Lymphoma, Non-H... Myelodysplastic... Primary Immunod... Anemia, Aplasti... Osteopetrosis Hemoglobinopath... Cytopenia Fanconi Anemia Diamond Blackfa... Thalassemia Anemia, Sickle ... | BPX-501 T cells Rimiducid | 1 Month - 18 Years | Bellicum Pharmaceuticals | |
| Repurposing Metformin as a Leukemia-preventive Drug in CCUS and LR-MDS | NCT04741945 | Preleukemia Myelodysplastic... Cytopenia Preleukemic Ane... | Metformin | 18 Years - | Rigshospitalet, Denmark | |
| Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study | NCT03733249 | Acute Lymphobla... Leukemia, Acute... Lymphoma, Non-H... Myelodysplastic... Primary Immunod... Anemia, Aplasti... Hemoglobinopath... Cytopenia Fanconi Anemia Diamond Blackfa... Thalassemia Anemia, Sickle ... | Rimiducid rivogenlecleuce... | 1 Month - 18 Years | Bellicum Pharmaceuticals | |
| Pre-myeloid Cancer and Bone Marrow Failure Clinic Study | NCT02958462 | Myeloid Maligna... Inherited Bone ... Clonal Expansio... Cytopenia Bone Marrow Fai... Clonal Cytopeni... Clonal Hematopo... Hematologic Neo... Hematopoietic a... Hereditary Neop... Idiopathic Cyto... Idiopathic Dysp... Low Risk Myelod... | Biospecimen Col... Bone Marrow Bio... Punch Biopsy Buccal Swab Clinical Evalua... Genetic Counsel... Quality-of-Life... Electronic Heal... | 18 Years - | Mayo Clinic | |
| JSP191 (Briquilimab) in Subjects With LR-MDS | NCT05903274 | Lower-risk Myel... | JSP191 | 18 Years - | Jasper Therapeutics, Inc. | |
| Screening for Hematology Branch Protocols | NCT00001620 | Hematologic Dis... Donors Healthy Volunte... | 2 Years - 100 Years | National Institutes of Health Clinical Center (CC) | ||
| Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies | NCT03682029 | Myelodysplastic... Chronic Myelomo... Cytopenia | Vitamin C (asco... Placebo | 18 Years - | Rigshospitalet, Denmark | |
| Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies | NCT03682029 | Myelodysplastic... Chronic Myelomo... Cytopenia | Vitamin C (asco... Placebo | 18 Years - | Rigshospitalet, Denmark | |
| A Study of Emapalumab for Pediatric Aplastic Anemia | NCT06430788 | Aplastic Anemia Cytopenia Hypocellular Ma... | Emapalumab | 0 Years - 25 Years | Memorial Sloan Kettering Cancer Center | |
| Screening for Hematology Branch Protocols | NCT00001620 | Hematologic Dis... Donors Healthy Volunte... | 2 Years - 100 Years | National Institutes of Health Clinical Center (CC) | ||
| Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant | NCT02065869 | Acute Lymphobla... Leukemia, Acute... Lymphoma, Non-H... Myelodysplastic... Primary Immunod... Anemia, Aplasti... Osteopetrosis Hemoglobinopath... Cytopenia Fanconi Anemia Diamond Blackfa... Thalassemia Anemia, Sickle ... | BPX-501 T cells Rimiducid | 1 Month - 18 Years | Bellicum Pharmaceuticals | |
| Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine | NCT01928537 | Myelodysplastic... Refractory Anem... Chronic Myelomo... Cytopenia | rigosertib sodi... | 18 Years - | Traws Pharma, Inc. | |
| Low Bacterial Diet in Patients With Cytopenia | NCT00367588 | Cytopenia | Low bacterial d... | 18 Years - | Maastricht University Medical Center | |
| HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy | NCT02143830 | Fanconi Anemia Severe Marrow F... Myelodysplastic... Acute Myelogeno... | Busulfan Cyclophosphamid... Fludarabine rabbit ATG G-CSF Peripheral bloo... | 3 Months - | Children's Hospital Medical Center, Cincinnati | |
| Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies | NCT03682029 | Myelodysplastic... Chronic Myelomo... Cytopenia | Vitamin C (asco... Placebo | 18 Years - | Rigshospitalet, Denmark | |
| LBH589 Alone or in Combination With Erythropoietin Stimulating Agents (ESA) in Patients With Low or Int-1 Risk Myelodysplastic Syndromes (MDS) | NCT01034657 | Myelodysplastic... | LBH589 Epoetin Alfa | 18 Years - | Novartis | |
| Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer | NCT00771810 | Thrombocytopeni... Neutropenia Lymphopenia Anemia | TXA127 TXA127 Placebo | 18 Years - | Tarix Pharmaceuticals | |
| A Study of KER-050 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes | NCT04419649 | Myelodysplastic... Cytopenia | KER-050 | 18 Years - | Keros Therapeutics, Inc. | |
| LBH589 Alone or in Combination With Erythropoietin Stimulating Agents (ESA) in Patients With Low or Int-1 Risk Myelodysplastic Syndromes (MDS) | NCT01034657 | Myelodysplastic... | LBH589 Epoetin Alfa | 18 Years - | Novartis | |
| A Study of KER-050 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes | NCT04419649 | Myelodysplastic... Cytopenia | KER-050 | 18 Years - | Keros Therapeutics, Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
